Cardiovascular system recommendations
On this page you will find our recommendations sorted by BNF chapter.
Appraisal Reports are available to stakeholders on request.
Where a decision is >24 months old; these are highlighted in red. If you are a clinician working within the NTAG region and would like to prioritise an old decision for re-review please contact the professional secretary on nuth.nyrdtc.rxsupp@nhs.net
| Title | Documents | Decision | Date | |
|---|---|---|---|---|
| Left atrial appendage occlusion devices for stroke prevention in patients with non-valvular atrial fibrillation (NETAG) | Recommendation | Recommended for patients with a proven bleeding risk which contraindicates anticoagulation therapy | 10/07/2012 | |
| Stand-alone minimally invasive bipolar radiofrequency ablation for Atrial Fibrillation (NETAG) | Recommendation | Recommended for atrial fibrillation where catheter ablation is not suitable due to clinical, technical or anatomical reasons | 12/07/2011 | |
| Top Tips and Recommendations for Sodium Glucose Co-transporter 2 inhibitors (SGLT2i) in HFrEF | SGLT2 in Heart Failure Top Tips NTAG v1 - approved June 2022 | Approved by NTAG | 07/06/2022 | |
| NENC Patient Specific Factors to Consider When Choosing a DOAC in NVAF | NENC Decision Aid incl Table to support decison of DOAC in AF - approved June 2022 - final | Approved by NTAG | 07/06/2022 | |
|
Updated 20/09/2022 |
Northern England Evaluation and Lipid Intensification guideline | NEELI edit v2022.2-FINAL-NTAG | Approved by NTAG | 06/09/2022 |